Content area

|
|

Genomet og farmakologien

Forfatter(e)
Kim Brøsen1 & Per Damkier2 1) Institut for Sundhedstjenesteforskning, Klinisk Farmakologi, Syddansk Universitet 2) Afdeling for Klinisk Biokemi og Farmakologi, Odense Universitetshospital Ugeskr Læger 2014;176:V06140350
Reference: 
Ugeskr Læger 2014;176:V06140350
Blad nummer: 
Sidetal: 
2183-2186
The genome and pharmacology
Pharmacogenetics is the science about how germ line mutations affect the response to drugs, and the role of single nucleotide polymorphisms in cytochrome P450 genes (CYP) has been particularly well studied during the last 25 years. The current knowledge about CYP2C9, VKORC1 and warfarin, CYP2C19 and clopidogrel, CYP2D6 and tamoxifen and CYP3A5 and tacrolimus is summarized, and it is concluded that genotyping before treatment seems to be of little practical use for all four drugs. The same applies to simvastatin and SLCOB1 and metformin and OCT1 transporter polymorphisms.
Du skal være logget ind for at læse denne artikel
Log ind

Right side

af Poul Erik Rørbæk | 03/06
3 kommentarer
af Kristine Rasmussen | 03/06
1 Kommentar
af Theodóra Hannesdóttir Cleemann | 02/06
3 kommentarer
af Bjørn Erik Ejbye Sørensen | 26/05
2 kommentarer